Table 4.
Clinically used compounds
| Compound | Effect at 14 DIV |
|---|---|
| Morphine | No effect ≦5 μM |
| Duloxetine | IC50 = 0.62 μM |
| Amitriptyline | IC50 = 1.3 μM |
| Gabapentin | Decreased spontaneous activity at 1 mM |
| Carbamazepine | IC50 = 16.2 μM |
Clinically used compounds
| Compound | Effect at 14 DIV |
|---|---|
| Morphine | No effect ≦5 μM |
| Duloxetine | IC50 = 0.62 μM |
| Amitriptyline | IC50 = 1.3 μM |
| Gabapentin | Decreased spontaneous activity at 1 mM |
| Carbamazepine | IC50 = 16.2 μM |